| answer text |
<p>The Department is doing everything appropriate to prepare for leaving the European
Union. We want to reassure patients that our plans should ensure the uninterrupted
supply of medicines and medical products once we have left the EU.</p><p>The Department,
as part of our EU exit preparations, has analysed the supply chains of over 12,000
licensed medicines used by patients in the United Kingdom and close to half a million
product lines of medical devices and clinical consumables with an EU/European Economic
Area touchpoint. This approach means that the medicines and medical equipment used
by people living with disabilities are included within our planning.</p><p>We continue
to implement a multi-layered approach to mitigate potential disruption to supply,
which consists of stockpiling where possible, securing freight capacity, changing
or clarifying regulatory requirements, procuring additional warehousing, working closely
with industry to improve trader readiness and putting in place the National Supply
Disruption Response to manage potential shortages. Further details can be found at
the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans"
target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a>.</p><p>
</p>
|
|
